Profile data is unavailable for this security.
About the company
LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Its portfolio of product lines is primarily used to treat vascular disease, of which most are used in open vascular surgery and dialysis access. It also offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy catheters, occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. The Company’s principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. The Company sells its products and services primarily through a direct sales force.
- Revenue in USD (TTM)193.48m
- Net income in USD30.11m
- Incorporated1998
- Employees614.00
- LocationLeMaitre Vascular Inc63 2nd AveBURLINGTON 01803-4413United StatesUSA
- Phone+1 (781) 221-2266
- Fax+1 (781) 425-5049
- Websitehttps://www.lemaitre.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avanos Medical Inc | 673.30m | -9.90m | 824.74m | 3.77k | -- | 0.6667 | 22.78 | 1.22 | -0.2092 | -1.32 | 14.43 | 26.77 | 0.387 | 1.66 | 4.73 | 178,546.80 | -0.5691 | -0.6527 | -0.6473 | -0.7338 | 56.39 | 54.45 | -1.47 | -1.60 | 1.38 | 4.27 | 0.1196 | -- | -1.58 | 0.6357 | -146.05 | -- | -18.37 | -- |
| Artivion Inc | 354.00m | -30.57m | 845.46m | 1.50k | -- | 2.96 | -- | 2.39 | -0.7496 | -0.7496 | 8.68 | 6.86 | 0.4553 | 1.60 | 5.30 | 236,002.70 | -3.95 | -2.20 | -4.24 | -2.36 | 64.74 | 65.51 | -8.67 | -5.34 | 3.43 | 0.6809 | 0.5246 | -- | 12.82 | 6.14 | -60.09 | -- | 5.13 | -- |
| MiMedx Group Inc | 321.48m | 55.80m | 917.76m | 895.00 | 24.20 | 6.40 | 14.31 | 2.85 | 0.2581 | 0.2192 | 2.19 | 0.976 | 1.57 | 3.19 | 6.63 | 359,192.20 | 32.86 | -4.14 | 42.03 | -5.90 | 83.01 | 83.61 | 20.98 | -2.70 | 3.11 | 7.11 | 0.256 | -- | 20.03 | -2.19 | 310.29 | -- | -26.47 | -- |
| Perspective Therapeutics Inc | 8.17m | -25.10m | 939.51m | 88.00 | -- | 4.55 | -- | 114.98 | -0.1012 | -0.1012 | 0.0351 | 0.352 | 0.0944 | 4.91 | 5.55 | 92,852.27 | -29.01 | -- | -31.19 | -- | 22.96 | -- | -307.18 | -- | 2.55 | -- | 0.0173 | -- | -- | -- | -- | -- | -- | -- |
| AtriCure Inc | 399.25m | -30.44m | 1.09bn | 1.20k | -- | 2.31 | -- | 2.74 | -0.6569 | -0.6569 | 8.62 | 9.81 | 0.6658 | 1.74 | 8.39 | 332,704.20 | -5.08 | -3.72 | -5.71 | -4.10 | 75.23 | 74.36 | -7.62 | -7.64 | 2.66 | -8.52 | 0.1301 | -- | 20.84 | 14.64 | 34.49 | -- | 46.56 | -- |
| Coretag Inc | 0.00 | -39.35k | 1.13bn | -- | -- | -- | -- | -- | -0.4372 | -0.4372 | 0.00 | -0.93 | 0.00 | -- | -- | -- | -78,700.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 10.95 | -- | -- | -- |
| Adapthealth Corp | 3.20bn | -678.90m | 1.27bn | 10.70k | -- | 0.8712 | -- | 0.3979 | -5.06 | -5.06 | 23.77 | 11.00 | 0.6579 | 21.79 | 8.56 | 299,082.00 | -13.87 | -4.34 | -15.48 | -4.89 | 17.82 | 18.28 | -21.09 | -6.47 | 0.997 | 1.83 | 0.5978 | -- | 7.73 | -- | -1,169.99 | -- | -- | -- |
| Establishment Labs Holdings Inc | 165.15m | -78.50m | 1.33bn | 908.00 | -- | 68.84 | -- | 8.07 | -3.05 | -3.05 | 6.45 | 0.7051 | 0.6886 | 1.00 | 4.01 | 181,884.40 | -32.73 | -33.22 | -40.93 | -41.12 | 64.78 | 64.73 | -47.53 | -43.19 | 1.67 | -13.08 | 0.9112 | -- | 2.13 | 21.96 | -4.38 | -- | 69.16 | -- |
| LeMaitre Vascular Inc | 193.48m | 30.11m | 1.41bn | 614.00 | 46.92 | 4.72 | 35.69 | 7.31 | 1.34 | 1.34 | 8.63 | 13.34 | 0.5888 | 1.23 | 8.22 | 315,120.50 | 9.16 | 9.02 | 10.00 | 9.93 | 65.66 | 65.83 | 15.56 | 15.45 | 4.57 | -- | 0.00 | 40.41 | 19.69 | 12.88 | 45.89 | 5.96 | 18.93 | 15.51 |
| Inmode Ltd | 492.05m | 197.92m | 1.44bn | 581.00 | 7.38 | 1.82 | 7.25 | 2.93 | 2.30 | 2.30 | 5.73 | 9.38 | 0.6527 | 1.90 | 14.19 | 846,898.40 | 26.25 | 31.32 | 29.07 | 35.64 | 83.60 | 84.46 | 40.22 | 39.65 | 12.48 | -- | 0.00 | 0.00 | 8.32 | 37.49 | 22.54 | 54.65 | 13.10 | -- |
| Warby Parker Inc | 669.77m | -63.20m | 1.51bn | 2.14k | -- | 4.99 | -- | 2.25 | -0.5376 | -0.5376 | 5.71 | 2.55 | 1.17 | 4.65 | 416.78 | 312,974.30 | -11.00 | -- | -14.16 | -- | 54.53 | 57.49 | -9.44 | -14.53 | 1.86 | -- | 0.00 | -- | 11.98 | 19.67 | 42.75 | -- | -- | -- |
| UFP Technologies Inc | 400.07m | 44.92m | 1.60bn | 3.09k | 35.93 | 5.60 | 28.44 | 4.00 | 5.84 | 5.84 | 51.97 | 37.45 | 1.02 | 4.65 | 6.69 | 129,347.20 | 11.48 | 9.69 | 13.45 | 10.95 | 28.05 | 26.33 | 11.23 | 10.14 | 1.28 | 15.86 | 0.101 | 0.00 | 13.08 | 16.00 | 7.50 | 25.71 | 14.08 | -- |
| Alphatec Holdings Inc | 482.26m | -186.64m | 1.69bn | 839.00 | -- | 21.82 | -- | 3.50 | -1.54 | -1.54 | 3.98 | 0.7305 | 0.7273 | 1.44 | 7.06 | 574,805.80 | -28.15 | -30.97 | -36.25 | -39.47 | 64.32 | 66.02 | -38.70 | -46.22 | 1.99 | -5.40 | 0.8345 | -- | 37.45 | 39.38 | -23.36 | -- | 67.92 | -- |
| Owens & Minor, Inc. | 10.33bn | -41.30m | 1.85bn | 13.70k | -- | 2.00 | 7.51 | 0.1788 | -0.5479 | -0.5479 | 136.31 | 12.07 | 1.97 | 6.72 | 15.18 | 754,304.20 | -0.7882 | 1.32 | -1.18 | 2.07 | 20.56 | 16.48 | -0.3997 | 0.5614 | 0.5244 | 2.04 | 0.6944 | 0.798 | 3.80 | 1.87 | -284.47 | -- | 25.91 | -- |
| Conmed Corp | 1.26bn | 82.35m | 1.91bn | 4.00k | 23.70 | -- | 12.35 | 1.51 | 2.61 | 2.61 | 39.97 | -- | -- | -- | -- | 315,387.00 | -- | 0.8972 | -- | 1.02 | 54.94 | 54.95 | 6.53 | 1.65 | -- | 3.76 | -- | 139.16 | 19.06 | 7.68 | 179.99 | 10.04 | 2.89 | 0.00 |
Data as of Apr 25 2024. Currency figures normalised to LeMaitre Vascular Inc's reporting currency: US Dollar USD
54.38%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 31 Dec 2023 | 3.02m | 13.54% |
| Conestoga Capital Advisors LLCas of 31 Dec 2023 | 1.93m | 8.63% |
| The Vanguard Group, Inc.as of 31 Dec 2023 | 1.49m | 6.69% |
| Copeland Capital Management LLCas of 31 Mar 2024 | 1.29m | 5.78% |
| Ranger Investment Management LPas of 31 Dec 2023 | 912.50k | 4.09% |
| Geneva Capital Management LLCas of 31 Dec 2023 | 904.72k | 4.05% |
| SSgA Funds Management, Inc.as of 31 Dec 2023 | 796.69k | 3.57% |
| Dimensional Fund Advisors LPas of 31 Dec 2023 | 670.76k | 3.00% |
| Congress Asset Management Co. LLPas of 31 Mar 2024 | 666.08k | 2.98% |
| Geode Capital Management LLCas of 31 Dec 2023 | 458.54k | 2.05% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
